U-Blot® Research Grade BesilesomabCat. No. WA2512$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade BesilesomabCat. No. WA2512
U-Blot® Research Grade beruzatatugCat. No. WA2511
U-Blot® Research Grade BertilimumabCat. No. WA2510
U-Blot® Research Grade BersanlimabCat. No. WA2509
U-Blot® Research Grade BermekimabCat. No. WA2508
U-Blot® Research Grade BerlimatoxumabCat. No. WA2507
U-Blot® Research Grade Berahyaluronidase AlfaCat. No. WA2506
U-Blot® Research Grade BepranemabCat. No. WA2505
U-Blot® Research Grade BenufutamabCat. No. WA2504
U-Blot® Research Grade BentracimabCat. No. WA2503
U-Blot® Research Grade BenralizumabCat. No. WA2502
U-Blot® Research Grade BenmelstobartCat. No. WA2501